• Dom. Dic 22nd, 2024

NIH

  • Home
  • Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024

Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according…

Smoking cannabis associated with increased risk of heart attack, stroke

Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke, according to an observational study supported by the National Institutes of Health. The study, published in…

Antibody reduces allergic reactions to multiple foods in NIH clinical trial

A 16-week course of a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume…

Researchers optimize genetic tests for diverse populations to tackle health disparities

To prevent an emerging genomic technology from contributing to health disparities, a scientific team funded by the National Institutes of Health has devised new ways to improve a genetic testing…

Switching to vegan or ketogenic diet rapidly impacts immune system

Researchers at the National Institutes of Health observed rapid and distinct immune system changes in a small study of people who switched to a vegan or a ketogenic (also called…

275 million new genetic variants identified in NIH precision medicine data

Researchers have discovered more than 275 million previously unreported genetic variants, identified from data shared by nearly 250,000 participants of the National Institutes of Health’s All of Us Research Program.…